BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ecker BL, McMillan MT, Datta J, Lee MK, Karakousis GC, Vollmer CM Jr, Drebin JA, Fraker DL, Roses RE. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database. Cancer. 2017;123:967-976. [PMID: 28263387 DOI: 10.1002/cncr.30439] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Augustin T, Moslim MA, Cengiz TB, El-Hayek K, Simon R, Bhatt A, Tang A, Burke CA, Matthew Walsh R. Survival outcomes after surgical management of sporadic or familial adenomatous polyposis associated duodenal cancer. J Surg Oncol 2020;122:1132-44. [PMID: 33124067 DOI: 10.1002/jso.26131] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Gelsomino F, Balsano R, De Lorenzo S, Garajová I. Small Bowel Adenocarcinoma: From Molecular Insights to Clinical Management. Current Oncology 2022;29:1223-36. [DOI: 10.3390/curroncol29020104] [Reference Citation Analysis]
3 Li D, Si X, Wan T, Zhou Y. Outcomes of surgical resection for primary duodenal adenocarcinoma: A systematic review. Asian J Surg 2019;42:46-52. [PMID: 29802028 DOI: 10.1016/j.asjsur.2018.04.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
4 Lim YJ, Kim K. Effect of postoperative radiotherapy on survival in duodenal adenocarcinoma: a propensity score-adjusted analysis of Surveillance, Epidemiology, and End Results database. Int J Clin Oncol 2018;23:473-81. [DOI: 10.1007/s10147-017-1226-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Chandrasegaram MD, Gill AJ, Samra J, Price T, Chen J, Fawcett J, Merrett ND. Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer. World J Gastrointest Oncol 2017; 9(10): 407-415 [PMID: 29085567 DOI: 10.4251/wjgo.v9.i10.407] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
6 Zhao P, Chen H, Wen D, Mou S, Zhang F, Zheng S. Personalized treatment based on mini patient-derived xenografts and WES/RNA sequencing in a patient with metastatic duodenal adenocarcinoma. Cancer Commun (Lond) 2018;38:54. [PMID: 30139386 DOI: 10.1186/s40880-018-0323-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
7 Ecker BL, Vining CC, Roses RE, Maggino L, Lee MK, Drebin JA, Fraker DL, Vollmer CM, Datta J. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis. Ann Surg Oncol. 2017;24:3926-3933. [PMID: 28952140 DOI: 10.1245/s10434-017-6095-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
8 Turpin A, El Amrani M, Zaanan A. Localized Small Bowel Adenocarcinoma Management: Evidence Summary. Cancers (Basel) 2022;14:2892. [PMID: 35740558 DOI: 10.3390/cancers14122892] [Reference Citation Analysis]
9 Zhao J, Li X, Liu Q, Shi L, Zhang L, Yang H, Zhang Q. Clinical comparative analysis of various duodenal diseases in different age groups. Turk J Gastroenterol 2020;31:489-96. [PMID: 32897221 DOI: 10.5152/tjg.2020.18712] [Reference Citation Analysis]
10 Mann K, Gilbert T, Cicconi S, Jackson R, Whelan P, Campbell F, Halloran C, Neoptolemos J, Ghaneh P. Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma. Langenbecks Arch Surg 2019;404:439-49. [PMID: 30972486 DOI: 10.1007/s00423-019-01779-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
11 de Bakker JK, Meijer LL, Zonderhuis BM, van der Vliet HJ, Daams F, van Grieken NCT, Lissenberg-Witte BI, Kazemier G. Adjuvant chemotherapy for resected duodenal adenocarcinoma: a case-matched analysis in nation wide cohort. Acta Chir Belg 2022;:1-7. [PMID: 35727126 DOI: 10.1080/00015458.2022.2092961] [Reference Citation Analysis]
12 Jang B, Park HJ, Kim K, Jang J, Kim SW, Oh D, Chie EK. Role of Adjuvant Chemoradiotherapy for Duodenal Cancer: An Updated Analysis of Long-Term Follow-Up from Single Institution. World J Surg 2018;42:3294-301. [DOI: 10.1007/s00268-018-4692-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
13 Kaslow SR, Prendergast K, Vitiello GA, Hani L, Berman RS, Lee AY, Correa-gallego C. Systemic therapy for duodenal adenocarcinoma: An analysis of the National Cancer Database (NCDB). Surgery 2022. [DOI: 10.1016/j.surg.2022.03.009] [Reference Citation Analysis]
14 Dave A, Wiseman JT, Cloyd JM. Duodenal adenocarcinoma: neoadjuvant and adjuvant therapy strategies. Expert Opinion on Orphan Drugs 2019;7:463-72. [DOI: 10.1080/21678707.2019.1684257] [Reference Citation Analysis]
15 Zhang C, Wang GX, Zhu B. Application of antigen presenting cell-targeted nanovaccine delivery system in rhabdovirus disease prophylactics using fish as a model organism. J Nanobiotechnology 2020;18:24. [PMID: 32000788 DOI: 10.1186/s12951-020-0584-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
16 He C, Mao Y, Wang J, Duan F, Lin X, Li S. Nomograms predict long-term survival for patients with periampullary adenocarcinoma after pancreatoduodenectomy. BMC Cancer. 2018;18:327. [PMID: 29580215 DOI: 10.1186/s12885-018-4240-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
17 Lee TC, Wima K, Morris MC, Winer LK, Sussman JJ, Ahmad SA, Wilson GC, Patel SH. Small Bowel Adenocarcinomas: Impact of Location on Survival. J Surg Res 2020;252:116-24. [PMID: 32278965 DOI: 10.1016/j.jss.2020.03.017] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Hade EM, Bogner J, Corrigan JD, Horn SD, Peng J. Comparative Effectiveness of Inpatient Rehabilitation Interventions for Traumatic Brain Injury: Introduction. Arch Phys Med Rehabil 2019;100:1986-9. [PMID: 31561814 DOI: 10.1016/j.apmr.2019.04.007] [Reference Citation Analysis]
19 Zhu Z, Zhong F. Comparative Analysis of Outcomes and Clinicopathological Characteristics of Duodenal Adenocarcinoma: A SEER Analysis. Cancer Invest 2020;38:543-8. [PMID: 33073637 DOI: 10.1080/07357907.2020.1824260] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Ye X, Zhang G, Chen H, Li Y. Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma. PLoS One 2018;13:e0200204. [PMID: 30096150 DOI: 10.1371/journal.pone.0200204] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
21 Li N, Shen W, Deng W, Yang H, Ma Y, Bie L, Wei C, Luo S. Clinical features and the efficacy of adjuvant chemotherapy in resectable small bowel adenocarcinoma: a single-center, long-term analysis. Ann Transl Med 2020;8:949. [PMID: 32953749 DOI: 10.21037/atm-20-1503] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 de Bree E, Rovers KP, Stamatiou D, Souglakos J, Michelakis D, de Hingh IH. The evolving management of small bowel adenocarcinoma. Acta Oncol 2018;57:712-22. [PMID: 29381126 DOI: 10.1080/0284186X.2018.1433321] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
23 Falcone R, Romiti A, Filetti M, Roberto M, Righini R, Botticelli A, Pilozzi E, Ghidini M, Pizzo C, Mazzuca F, Marchetti P. Impact of tumor site on the prognosis of small bowel adenocarcinoma. Tumori Journal 2019;105:524-8. [DOI: 10.1177/0300891619839297] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Meijer LL, Alberga AJ, de Bakker JK, van der Vliet HJ, Le Large TYS, van Grieken NCT, de Vries R, Daams F, Zonderhuis BM, Kazemier G. Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis. Ann Surg Oncol. 2018;25:2681-2692. [PMID: 29946997 DOI: 10.1245/s10434-018-6567-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]